Pascal J. Goldschmidt, M.D., F.A.C.C.

Senior Vice President for Medical Affairs and Dean
Professor of Medicine

tel: 305-243-5554
fax: 305-243-5819

For Patients

Board Certifications
American Board of Internal Medicine

Practice Locations
Jackson Memorial Hospital
University of Miami Hospital/Sylvester

Languages Spoken
English, French, Creole (Conversational), Dutch, Spanish

Appointments
For an appointment, please call 305-243-6545 or use our online appointment form

Education

Johns Hopkins University
Baltimore, MD 		Fellowship Cardiology 1991
Union Memorial Hospital
Baltimore, MD 		Residency Medicine 1988
Medical University of South Carolina
Charleston, SC 		Fellowship Research 1986
Universite Libre de Bruxelles
Brussels, Belgium		 Residency Medicine/Cardiology 1983
Universite Libre de Bruxelles
Brussels, Belgium		 B.A. 1980
Universite Libre de Bruxelles
Brussels, Belgium		 B.S. 1976

Areas of Specialization

  • Management of myocardial infarction
  • Diagnosis and prevention of atherosclerosis
  • Platelet function and thrombosis
  • Genetics of coronary artery disease
  • Stem cell prevention of atherosclerosis

Pascal J. Goldschmidt, M.D., is senior vice president for medical affairs and dean of the University of Miami Miller School of Medicine. He also holds an academic appointment as professor in the Division of Cardiology at the University of Miami Miller School of Medicine. A native of Belgium, Dr. Goldschmidt received his medical degree from the Universite Libre de Bruxelles and completed residency and fellowship training at Erasme Academic Hospital, Brussels, Belgium, the Medical University of South Carolina and Johns Hopkins University. He was chairman of the Department of Medicine at Duke University Medical Center from 2003-2006. Before joining the Duke faculty in 2000, he was director of cardiology at The Ohio State University College of Medicine and Public Health, where he built the Heart and Lung Research Institute and a heart hospital.

Dr. Goldschmidt has served as principal investigator on a number of studies focused on identifying the genetic factors that predispose patients to heart attacks. His team discovered that a gene variant, PLA2, increases the risk for clot formation within coronary vessels. He and his team have observed many genes responsible for susceptibility for coronary artery disease and also were first to observe that arterial repair by endothelial progenitor cells becomes deficient with aging in the presence of risk factors for atherosclerosis.